Details for New Drug Application (NDA): 210342
✉ Email this page to a colleague
The generic ingredient in BOSENTAN is bosentan. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bosentan profile page.
Summary for 210342
Tradename: | BOSENTAN |
Applicant: | Chartwell Molecular |
Ingredient: | bosentan |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 62.5MG | ||||
Approval Date: | Jan 3, 2020 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
Approval Date: | Jan 3, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription